Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin-Induced Thrombocytopenia”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Testing effectiveness (Phase 2)Ended earlyNCT00673439
What this trial is testing

Fondaparinux for the Treatment of Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
University of Louisville 3
Not applicableUnknownNCT00510432
What this trial is testing

Incidence and Nature of Heparin-induced Skin Lesions in Medical Patients

Who this might be right for
Allergy
Johann Wolfgang Goethe University Hospital 500
Large-scale testing (Phase 3)Study completedNCT00073580
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing Off-Pump Coronary Artery Bypass Grafting (CABG) (CHOOSE)

Who this might be right for
ThrombocytopeniaThrombosisCardiac Disease+1 more
The Medicines Company 88
Not applicableUnknownNCT05586854
What this trial is testing

Multicenter Study on Dialysis Modalities for End-stage Chronic Renal Failure Patients With Heparin-induced Thrombocytopenia

Who this might be right for
Dialysis; ComplicationsHeparin-induced ThrombocytopeniaChronic Renal Failure
GCS Ramsay Santé pour l'Enseignement et la Recherche 20
Large-scale testing (Phase 3)Study completedNCT00079508
What this trial is testing

Angiomax in Patients With HIT/HITTS Type II Undergoing CPB

Who this might be right for
Cardiovascular DiseaseCoronary Artery Bypass Surgery
The Medicines Company 125
Not applicableUnknownNCT00198575
What this trial is testing

A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients

Who this might be right for
Heparin-Induced Thrombocytopenia
Ministry of Health, Labour and Welfare, Japan 1,500
Not applicableStudy completedNCT01304238
What this trial is testing

Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II

Who this might be right for
Acute HIT II (Heparin-induced Thrombocytopenia Type II)
GlaxoSmithKline 195
Large-scale testing (Phase 3)Study completedNCT00329433
What this trial is testing

Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

Who this might be right for
Deep Venous Thrombosis
Washington University School of Medicine 120
Not applicableStudy completedNCT05439265
What this trial is testing

EMR Tool Impact on HIT Documentation and Management

Who this might be right for
HeparinThrombocytopeniaElectronic Health Records
Rush University Medical Center 128
Not applicableStudy completedNCT00456001
What this trial is testing

Heparin Induced Thrombocytopenia: Pharmacoeconomics

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Brigham and Women's Hospital 200
Not applicableUnknownNCT04751357
What this trial is testing

Argatroban Monitoring in Critically Ill Patients: Evaluation of a Novel Ecarin-based Bedside Test

Who this might be right for
Heparin-induced Thrombocytopenia
Medical University of Vienna 21
Post-approval studies (Phase 4)WithdrawnNCT00603824
What this trial is testing

Fondaparinux in Patients With Acute Heparin-Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Methodist Healthcare - Memphis
Not applicableUnknownNCT06180785
What this trial is testing

Performance Evaluation of the Biological Diagnosis of HIT

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
University Hospital, Strasbourg, France 894
Not applicableUnknownNCT00946400
What this trial is testing

Validating 4Ts for Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-Induced Thrombocytopenia
Medstar Health Research Institute 500
Not applicableStudy completedNCT01178333
What this trial is testing

Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study

Who this might be right for
Heparin Induced Thrombocytopenia
Carelon Research 668
Large-scale testing (Phase 3)Ended earlyNCT03809481
What this trial is testing

Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban

Who this might be right for
Heparin-induced Thrombocytopenia
Aspen Global Incorporated 7
Early research (Phase 1)Study completedNCT00412464
What this trial is testing

Pilot Dose Finding and Pharmacokinetic Study of Fondaparinux in Children With Thrombosis

Who this might be right for
ThrombosisHeparin-induced Thrombocytopenia
Children's Hospital Los Angeles 24
Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Not applicableStudy completedNCT02790567
What this trial is testing

Rapid Diagnosis of Heparin-Induced Thrombocytopenia in Surgical Critically Ill Patients

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
Centre Hospitalier Universitaire de Besancon 120
Not applicableUnknownNCT04782843
What this trial is testing

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Besancon 124
Next Page